|
Santner, S J; Dawson, P J; Tait, L et al. (2001) Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat 65:101-10
|
|
Strickland, L B; Dawson, P J; Santner, S J et al. (2000) Progression of premalignant MCF10AT generates heterogeneous malignant variants with characteristic histologic types and immunohistochemical markers. Breast Cancer Res Treat 64:235-40
|
|
Wang, B; Miller, F R (2000) Tyrosine phosphorylation of an erbB-2 related p90 protein induced by estrogen in human breast epithelial cells. Int J Oncol 16:1035-42
|
|
Miller, F R (2000) Xenograft models of premalignant breast disease. J Mammary Gland Biol Neoplasia 5:379-91
|
|
Miller, F R; Barnbabas, N; Liu, X et al. (1999) Differential display, subtractive hybridization, and application of methodology to search for point mutations to identify genetic defects responsible for progression in MCF10AT model of human breast disease. Electrophoresis 20:256-60
|
|
Wang, B; Soule, H D; Miller, F R (1997) Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines. Anticancer Res 17:4387-94
|
|
Miller, F R (1996) Models of progression spanning preneoplasia and metastasis: the human MCF10AneoT.TGn series and a panel of mouse mammary tumor subpopulations. Cancer Treat Res 83:243-63
|
|
Miller, F R; Bukowski, J (1994) Growth factors in mouse mammary cell interactions in vitro. Anticancer Res 14:2033-8
|
